|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Because small cell lung cancer spreads quickly throughout the body, treatment must include cancer-killing drugs (chemotherapy) taken by mouth or injected into the body. Chemotherapy may be combined with high-powered x-rays (radiation therapy).
Surgery is rarely used to treat small cell lung cancer. It is only considered if it is limited small cell lung cancer with only one tumor that hasn't spread. Chemotherapy or radiation will be needed after surgery. However, because the disease has usually spread by the time it is diagnosed, very few patients with small cell lung cancer are candidates for surgery.
Combination chemotherapy and radiation treatment is given to people with extensive small cell lung cancer. However, the treatment only helps relieve symptoms. It does not cure the disease.
Some patients with limited small cell lung cancer may receive radiation therapy to the head after they have completed treatment for the lung area. This method, called prophylactic cranial irradiation (PCI), helps prevent any lung cancer from spreading to the brain.
For additional information and resources, see cancer support group.
How well you do depends on how much the lung cancer has spread.
Without treatment, the average survival is 2 -4 months. Treatment can often prolong life to 6 - 12 months in patients with extensive disease. About 10% of patients with limited spread will show no evidence of cancer at 2 years.
This type of cancer is very deadly. Only about 6% of people with this type of cancer are still alive after 5 years.
Call your health care provider if you have symptoms of lung cancer (particularly if you smoke).
If you smoke, stop smoking. It's never too early to quit. Try to avoid secondhand smoke.
Routine screening for lung cancer is not recommended. Many studies have been done to look at the idea, but scientists have concluded that, at this time, screening would not help improve a person’s chance for a cure.
|
|
Reviewer Info: Sean O. Stitham, MD, private practice in Internal Medicine, Seattle, Washington; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.; ADAM Health Illustrated Encyclopedia, 09/04/2008 |